Tag: Eli Lilly
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?
Eli Lilly is the clear leader in the burgeoning weight loss...
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?
The pole position in the GLP-1 weight loss space is currently...
Is Eli Lilly a Buy Before 2026?
Eli Lilly’s next-generation obesity treatment may prove highly effective for patients...
This Skyrocketing Stock Has a Hidden Risk
Eli Lilly is currently the leader in the GLP-1 weight loss...
As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock?
Eli Lilly and Company (LLY) is a global pharmaceutical leader focused on discovering, developing, and commercializing...
Intel Soars Amid Apple Deal Rumors; Eli Lilly Stock Slides
The possibility of adding a new...
Retail Investors Really Don’t Like Novo Nordisk (NVO) Stock
Despite strong underlying fundamentals like a 71.5% return on equity...
Why Eli Lilly (LLY) Stock Is Trading Up Today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.9% in the afternoon...
Organon (OGN) Reports Earnings Tomorrow: What To Expect
Pharmaceutical company Organon (NYSE:OGN) will be announcing earnings results this Monday before market hours. Here’s what...
This Unstoppable Growth Stock Just Gave Investors More Reasons to Buy
Eli Lilly delivered fantastic third-quarter results, largely thanks to tirzepatide. The...
Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly
By Jacob Gronholt-Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed...
Nvidia says Eli Lilly will purchase more than 1,000 GPUs to power drug discovery efforts
Nvidia (NVDA) announced on Tuesday that drugmaker Eli Lilly (LLY) is building an AI supercomputer running...